GlaxoSmithkline Consumer Healthcare jumped 4.86% to Rs 4,207.60 at 11:15 IST on BSE after net profit rose 18.5% to Rs 156.41 crore on 15.6% growth in net sales to Rs 939.86 crore in Q1 March 2013 over Q1 March 2012.
The company announced Q1 results on Wednesday, 1 May 2013. The stock market was closed on that day on account of Maharashtra Day.
Meanwhile, the S&P BSE Sensex was up 239.94 points or 1.23% at 19,744.12.
On BSE, 2,199 shares were traded in the counter as against average daily volume of 2,418 shares in the past one quarter.
The stock hit a high of Rs 4,260 and a low of Rs 4,050 so far during the day. The stock had hit a record high of Rs 4,334 on 22 February 2013. The stock had hit a 52-week low of Rs 2,179 on 18 July 2012.
The stock had underperformed the market over the past one month till 30 April 2013, declining 4.16% compared with the Sensex's 3.55% rise. The scrip had, however, outperformed the market in past one quarter, jumping 8.32% as against Sensex's 2.5% fall.
Also Read
The large-cap company has equity capital of Rs 42.06 crore. Face value per share is Rs 10.
GlaxoSmithkline Consumer Healthcare is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.
Powered by Capital Market - Live News